Liquid formulations offer the advantage of dosing flexibility and ease of administration to young patients, but drug substances often show poor aqueous solubility.
As mentioned above, the DFS and OS advantages of dose density were not accompanied by an increase in toxicity.
1, 2, 16 Nevertheless, the potential benefits pertaining to safety and the advantages of dose-sparing on cost for this method have yet to be determined.
Thus, in view of the important advantages of dose banding in terms of production time gain and reduction of wastage, it is of primary importance to evaluate whether it can be shown to be no worse than BSA dosing.
The main advantages of dose banding are to reduce patient waiting time and improve pharmacy capacity planning; additional benefits include reduced medication errors, reduced drug wastage, and prospective quality control.
The main advantages of dose banding are to reduce patient waiting time and to improve capacity planning of the pharmacy production, but additional benefits can also be found, such as reduced potential for medication errors, reduced drug wastage, and prospective quality control of preparations.
Short-acting stimulants have the advantages of greater flexibility of dosing and lower cost.
The lack of need for dose adjustment has the advantages of easier dosing and a reduced risk of overdosing.
This approach takes advantage of dose dependent responses in the airways in mice exposed to HDM.
The complexity of these datasets requires advanced data analysis methods to take advantage of dose- and time-dependent features in toxicity assessment.
